Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.47 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21799410 | 0.85 | IRAK4 (0.43) | NPC1RAB9ADGAT1ALDH1A1SMN1; SMN2 | |
| SCHEMBL24505868 | 0.83 | NPC1 (0.54) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL21799389 | 0.83 | NPC1 (0.48) | NPC1RAB9ADGAT1LMNAALDH1A1 | |
| SCHEMBL21799397 | 0.82 | NPC1 (0.54) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL23234382 | 0.81 | NPC1 (0.44) | NPC1RAB9ADGAT1LMNAALDH1A1 | |
| SCHEMBL29050891 | 0.80 | NPC1 (0.46) | NPC1RAB9ADGAT1LMNAALDH1A1 | |
| SCHEMBL19019666 | 0.78 | NPC1 (0.74) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL29413953 | 0.78 | NPC1 (0.47) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL22983017 | 0.78 | NPC1 (0.47) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL30662294 | 0.78 | NPC1 (0.47) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11993578-B2 | Pyrazole-3-carboxylic acid amide derivative and pest control agent | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2024-05-28 | — | — | US | disclosed |
| EP-3623365-B1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2023-01-04 | — | — | EP | disclosed |
| US-20200199096-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3623365-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | Kumiai Chemical Industry Co., Ltd. (JP) | 2020-03-18 | — | — | EP | disclosed |
| CN-110612295-A | Pyrazole-3-carboxylic acid amide derivative and pest control agent | 组合化学工业株式会社 | 2019-12-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199096-A1 | PYRAZOLE-3-CARBOXYLIC ACID AMIDE DERIVATIVE AND PEST CONTROL AGENT | H1-3, HDAC3, H1-0 | NPC1 3658/4885RAB9A 166/4885DGAT1 1701/4885 |
| US-11993578-B2 | Pyrazole-3-carboxylic acid amide derivative and pest control agent | H1-3, HDAC3, H1-0 | NPC1 3658/4885RAB9A 166/4885DGAT1 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.